Loan AgreementLoan Agreement • August 21st, 2015 • Kitov Pharmaceuticals Holdings Ltd. • Pharmaceutical preparations
This Loan Agreement (the “Agreement”) is made as of the 12 day of August 2015 (the "Effective Date") by and among Kitov Pharmaceuticals Holdings Ltd., of 1 Azrieli Center 132 Menahem Begin Road Tel Aviv (the “Company”) and certain Lenders, as shall be specified in Exhibit A (the "Lenders") (each of the Company and the Lenders, a “Party”, and together, the "Parties").
development Services agreEmentDevelopment Services Agreement • August 21st, 2015 • Kitov Pharmaceuticals Holdings Ltd. • Pharmaceutical preparations
This Development Services Agreement (the "Agreement"), is made and entered into, as of ________________, 2014, by and between Kitov Pharmaceuticals Holdings Ltd., an Israeli company with offices at Lev Hagiva, 11 Bet Hadfus Street, Jerusalem 95483, Israel (hereinafter “Kitov”); and Dexcel Ltd., a company incorporated under the laws of Israel, with offices at 1 Dexcel Street Or Akiva, 3060000, Israel ("Dexcel").
Master Services Agreement Dated Between Kitov Pharmaceuticals Limited (Kitov)Master Services Agreement • August 21st, 2015 • Kitov Pharmaceuticals Holdings Ltd. • Pharmaceutical preparations
BRIEFLY DESCRIBE ORIGINAL ASSUMPTION AND NEW REQUEST: The Original MSA dated 04 February refers only to Java Professional and Pass through Fees. This change order reflects total agree PI Fees for both Republic of Ireland and Northern Ireland. ROI fees which will be paid in euro to Java Clinical Research ltd who will then pass it on to the PIs upon receipt of invoices. NI fees will be paid in sterling directly to the single Investigator site at Celerion. A detailed service agreement will be exchanged directly between Kitov Pharmaceuticals and Celerion.
